MedTrace Logo

Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia

NCT05349630 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2026-04-29

No results posted yet for this study

Summary

The purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.

Conditions

  • Right Ventricular Dysfunction
  • Hypoxia

Interventions

DRUG

Ferrous sulfate 325mg

Participants will take one tab of ferrous sulfate 325 mg (equivalent to 65 mg elemental iron) daily for 30 days.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2028-03-31
Primary Completion
2029-12-31
Completion
2030-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349630 on ClinicalTrials.gov